Cytomegalovirus (CMV) genotype

Alphabetical Test listing

Cytomegalovirus (CMV) genotype-994

  
Cytomegalovirus (CMV) genotype
  
994
  
LAB994
  
MSO
  
Cidofovir Resistance Genotyping
CMV Drug Resistance Genotyping
Foscarnet Resistance Genotyping
Ganciclovir Resistance Genotyping
UL54
UL97
  

Treatment of CMV diseases includes three licensed drugs: ganciclovir, foscarnet and cidofovir. All three drugs inhibit the viral DNA polymerase through various mechanisms. Over time, as CMV makes copies of itself, the virus can change its structure. These changes may make CMV resistant to the effects of antiviral drugs. Therefore, it is important to detect resistance as quickly and accurately as possible for proper management of CMV infection.

  
EDTA plasma
  
  
1.0 mL
  
0.3 mL
  
  1. Spin and separate within 2 hours of collection
  2. Transfer plasma to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp)
  3. Freeze

Avoid repeated freezing and thawing of specimen.

 

  
Cerebrospinal fluid (CSF)
Bronchial lavage/wash
  

Sterile vial/container

  

CSF - Freeze

BAL - Refrigerate

  

Sterile vial/container

  

Plasma/CSF: Frozen

BAL: Refrigerated

  
Focus Diagnostics Inc via LabCorp (009985): R-NX
  
Mo, We
  
5 - 8 days
  

DNA Sequencing Polymerase Chain Reaction (PCR)

  

An interpretive report will be provided

  
87910
  
05/20/2019
  
05/20/2019